Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMAssay Description:Compounds I-1 through I-50 of the invention were assayed in a mass spectrometric assay to measure their ability to covalently modify MK2 protein. The...More data for this Ligand-Target Pair